Search results
Exploring Novartis And Two More High-Yield Dividend Stocks In Switzerland
Simply Wall St. via Yahoo Finance· 2 days agoThe Switzerland market recently experienced a moderate decline, influenced by investor concerns that...
Community Calendar: June 14, 2024
Plattsburgh Press-Republican· 2 days agoCOMMUNITY CALENDAR
The 13 Best Tinted Sunscreens for Summer 2024, According to Editors
STYLECASTER via Yahoo News· 5 days agoLa Roche-Posay Anthelios Mineral Tinted...
Eli Lilly Pushes Alzheimer's Stocks Lower On FDA Win
Investor's Business Daily· 4 days agoDespite the stock move, analysts largely expect donanemab to gain FDA approval. Late Monday, the advisors to the FDA voted unanimously that the clinical...
2024 Emmys Drama Series Predictions
Variety via Yahoo News· 2 days agoVariety Awards Circuit section is the home for all awards news and related content throughout the year, featuring the following: the official predictions...
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D...
Morningstar· 5 days agoFN Media Group News Commentary - In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it was estimated by the National ...
What's in a Name: Defining Difficult-to-Treat axSpA and PsA
Medscape· 2 days agoDespite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with...
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer
MedPage Today· 4 days agoNo difference in PFS, median OS favored control group
Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma
MedPage Today· 6 days agoImmunotherapy may have been given too late, researchers suggested
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as...
Yucaipa News Mirror· 3 days agoPreviously, IBI343 has already received FDA approval of its IND application for the treatment of PDAC. At the ASCO 2024 Annual Meeting, Innovent reported the preliminary Phase 1< ...